Three down, two to go when it comes to major regulatory hurdles that Medtronic and Covidien need to clear for their proposed $43 billion merger. The U.S. Federal Trade Commission, the European Union and Canada’s Competition Bureau ...
FDA's Circulatory System Devices Advisory Panel has submitted a unanimous approval recommendation for C.R. Bard's Lutonix Drug Coated Balloon (DCB) Percutaneous Transluminal Angioplasty (PTA) catheter. If FDA follows the recommendations ...
Tags: Health, Medicine, FDA, Certification
Healthcare products company Covidien has purchased California-based CV Ingenuity, which is focused on improving patient outcomes in the treatment of vascular diseases. CV Ingenuity's core technology Drug Coated Balloon (DCB), which ...
Tags: healthcare, Covidien, CV, DCB, purchase
Vascular Nanotransfer Technologies has reported in vivo test results of its paclitaxel nanocarrier-based Drug Coated Balloon (DCB) technology, designed for patients with coronary in-stent restenosis and peripheral vascular disease. ...
Tags: Drug Coated Balloon, medical technology, clinical trial